Scientists tested an anti-aging drug on laboratory mice, extending their lifespan by 25%. The drug targets interleukin-11 protein, leading to healthier and stronger mice with fewer cancers. Results show a 20-25% increase in lifespan, with male mice gaining 22.5% and females 25%. Human trials are pending.
Key Points
Drug targets interleukin-11 protein
Researchers from multiple institutions conducted experiments
Results published in the science journal Nature
Male mice extended lifespan by 22.5%, females by 25%
Pros
Significantly extends the lifespan of laboratory mice
Mice are healthier, stronger, and develop fewer cancers